Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

New FDA Head Lifts Hiring Freeze, Takes Aim at the Next Martin Shkreli and Marathon Pharma

Two weeks after his confirmation, new U.S. Food and Drug Administration Commissioner Scott Gottlieb was already hard at work looking to hire additional staff and addressing ways to prevent speculator pharma companies from jacking up prices on drugs for which there is no generic equivalent.

Read More »

Walking linked to improved brain function

A moderate-intensity walking regimen may reduce symptoms of mild cognitive impairment that are linked to poor blood vessel health in the brain, a small study suggests.

Read More »

Havas Group Acquires Sorento, An India-based Health-and-Wellness Communications Agency

Havas Group is expanding its capabilities and footprint in the important and burgeoning Indian market by adding Sorento to its roster of agencies.

Read More »

Pfizer Biosimilar Recommended for U.S. Approval

The U.S. FDA Oncologic Drugs Advisory Committee recommended approval of Pfizer’s proposed epoetin alfa biosimilar across all indications.

Read More »

U.S. Alzheimer’s deaths jump 54 percent

U.S. deaths from Alzheimer’s disease rose by more than 50 percent from 1999 to 2014 – and rates are expected to continue to rise – reflecting the nation’s aging population and increasing life expectancy, American researchers said.

Read More »

FDA Advisory Committee Recommends Approval of Endari from Emmaus Life Sciences for the Treatment of Sickle Cell Disease

Emmaus Life Sciences Inc. announced that the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration voted 10-to-3 that the overall Benefit-Risk profile of Endari for the treatment of sickle cell disease (SCD) is favorable. The FDA has set a PDUFA target action date for July 7, 2017.

Read More »

10 Biotechs Awaiting FDA Decisions in June 2017

June has the potential to be a make-or-break month for a number of biotech companies. At least 10 are facing critical decisions by the U.S. Food and Drug Administration (FDA).

Read More »

Drug approvals bounce back in 2017

The number of new drugs approved for sale in United States and Europe has bounced back in 2017, suggesting a marked slowdown in 2016 was an aberration.

Read More »

Merck Enters Exclusive Worldwide License Agreement with Teijin Pharma for Investigational Antibody Candidate Targeting Tau

Merck announced that it has entered into an exclusive worldwide license agreement with Teijin Pharma for the development, manufacture and commercialization of an investigational preclinical antibody candidate targeting the protein tau. Changes in tau are associated with a number of diseases affecting the nervous system, including Alzheimer’s disease (AD).

Read More »

New MS Drug Linked to Deadly Brain Infection

Roche is investigating a case of a German patient diagnosed with a deadly brain infection called PML after taking one dose of the company’s new MS drug Ocrevus.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom